Cyclacel Pharmaceuticals (CYCC)

Add to Watchlists Create an Alert
2.97 -0.10  -3.26%   NASDAQ May 22, 4:59PM BATS Real time Currency in USD

Cyclacel Pharmaceuticals News

Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering
GlobeNewswire May 21

BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (Cyclacel or the Company), today announced that it has closed its previously announced underwritten offering of 6,833,334 shares of its common stock ...

Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering
GlobeNewswire May 16

BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public ...

Cyclacel Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 13

Cyclacel Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

Cyclacel Reports First Quarter 2013 Financial Results
GlobeNewswire May 13

BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment ...

Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results
GlobeNewswire May 10

BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment ...

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
CYCC 2.97 -0.10 -3.26% 32.32M
New watchlist
Create
Success.

Your new watchlist has been created

View WatchlistsDone
Create Watchlist from Quotes

Register for your Free YCharts Account.

Understand your investments with more data than any other free site.

  • Create watchlists that you care about for stocks or economic indicators
  • Create alerts to track the movements of your stocks
  • Access stock analysis from our in-house experts
Get Started Now

Already registered? Sign in to your account.

document.write('');